These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29435066)

  • 21. Prostratin, a nonpromoting phorbol ester, inhibits induction by phorbol 12-myristate 13-acetate of ornithine decarboxylase, edema, and hyperplasia in CD-1 mouse skin.
    Szallasi Z; Blumberg PM
    Cancer Res; 1991 Oct; 51(19):5355-60. PubMed ID: 1913657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV).
    Gulakowski RJ; McMahon JB; Buckheit RW; Gustafson KR; Boyd MR
    Antiviral Res; 1997 Jan; 33(2):87-97. PubMed ID: 9021050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostratin as a new therapeutic agent targeting HIV viral reservoirs.
    Hezareh M
    Drug News Perspect; 2005 Oct; 18(8):496-500. PubMed ID: 16391719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostratin: An Overview.
    Miana GA; Riaz M; Shahzad-ul-Hussan S; Paracha RZ; Paracha UZ
    Mini Rev Med Chem; 2015; 15(13):1122-30. PubMed ID: 25963564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hydroalcoholic Extract of
    Nikseresht M; Kamali AM; Rahimi HR; Delaviz H; Toori MA; Kashani IR; Mahmoudi R
    Pharmacognosy Res; 2017; 9(1):87-95. PubMed ID: 28250660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Krüppel-like factor 8 activates the transcription of C-X-C cytokine receptor type 4 to promote breast cancer cell invasion, transendothelial migration and metastasis.
    Mukherjee D; Lu H; Yu L; He C; Lahiri SK; Li T; Zhao J
    Oncotarget; 2016 Apr; 7(17):23552-68. PubMed ID: 26993780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minecoside Modulates Cell Invasion via Regulation of CXCR4 Expression in Breast and Colon Cancer Cells.
    Kim B; Min YH; Park B
    Planta Med; 2020 Mar; 86(5):331-337. PubMed ID: 32016931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods.
    Shi M; Zhou Y; Wei H; Zhang X; Du M; Zhou Y; Yin Y; Li X; Tang X; Sun L; Xu D; Li X
    Front Pharmacol; 2023; 14():1116098. PubMed ID: 37124223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV type 1 inhibition by protein kinase C modulatory compounds.
    Warrilow D; Gardner J; Darnell GA; Suhrbier A; Harrich D
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):854-64. PubMed ID: 16989610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinases C as potential host targets for the inhibition of chikungunya virus replication.
    Abdelnabi R; Amrun SN; Ng LF; Leyssen P; Neyts J; Delang L
    Antiviral Res; 2017 Mar; 139():79-87. PubMed ID: 28039020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
    Wang Y; Liang WC; Pan WL; Law WK; Hu JS; Ip DT; Waye MM; Ng TB; Wan DC
    Phytomedicine; 2014 Sep; 21(11):1310-7. PubMed ID: 25172795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
    Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis.
    Lombardi MS; Gilliéron C; Berkelaar M; Gabay C
    PLoS One; 2017; 12(10):e0185426. PubMed ID: 28973003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (-)‑Oleocanthal inhibits proliferation and migration by modulating Ca
    Diez-Bello R; Jardin I; Lopez JJ; El Haouari M; Ortega-Vidal J; Altarejos J; Salido GM; Salido S; Rosado JA
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):474-485. PubMed ID: 30321616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.